ArticleHealth science reports2026
Lung Cancer in Never Smokers-An Underappreciated Public Health Burden.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer in lifelong never-smokers represents a significant public health burden, although it is underappreciated. Lung cancer in never smokers (LCINS) accounts for a substantial proportion of lung cancer cases, representing ~15%-25% depending on the geographic region. If considered as a separate disease entity, LCINS would represent a major cause of cancer-related mortality. Discussion: Importantly, never-smokers with lung cancer have distinct epidemiology, molecular alterations, and therapeutic opportunities that differ from those of tobacco-related lung cancer. This perspective addresses lung cancer in lifelong never-smokers from four perspectives: epidemiology and incidence, molecular landscape and treatment, screening and early detection, and public health strategies. Conclusion: This perspective highlights that a comprehensive approach to lung cancer in never-smokers can meaningfully reduce the burden of disease through comprehensive screening approaches, stringent environmental regulations, molecular characterization of cancer, and educational approaches aimed at preventing disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.